상세 보기
The MCP-3/Ccr3 axis contributes to increased bone mass by affecting osteoblast and osteoclast differentiation
- Kim, Jung Ha;
- Kim, Kabsun;
- Kim, Inyoung;
- Seong, Semun;
- Che, Xiangguo;
- ... Choi, Je-Yong;
- 외 2명
WEB OF SCIENCE
6SCOPUS
6초록
Several CC subfamily chemokines have been reported to regulate bone metabolism by affecting osteoblast or osteoclast differentiation. However, the role of monocyte chemotactic protein 3 (MCP-3), a CC chemokine, in bone remodeling is not well understood. Here, we show that MCP-3 regulates bone remodeling by promoting osteoblast differentiation and inhibiting osteoclast differentiation. In a Ccr3-dependent manner, MCP-3 promoted osteoblast differentiation by stimulating p38 phosphorylation and suppressed osteoclast differentiation by upregulating interferon beta. MCP-3 increased bone morphogenetic protein 2-induced ectopic bone formation, and mice with MCP-3-overexpressing osteoblast precursor cells presented increased bone mass. Moreover, MCP-3 exhibited therapeutic effects by abrogating receptor activator of nuclear factor kappa-B ligand-induced bone loss. Therefore, MCP-3 has therapeutic potential for diseases involving bone loss due to its positive role in osteoblast differentiation and negative role in osteoclast differentiation. Our bones are always changing, needing a balance between bone creation and bone breakdown. Researchers investigates how a specific protein, MCP-3, affects this balance. They found that MCP-3 promotes the creation of osteoblasts and stops the creation of osteoclasts. The study involved both in vitro and in vivo methods, looking at how changing MCP-3 levels impacts bone change processes. Researchers found that increasing MCP-3 levels in bone-making cells resulted in stronger bones in mice, suggesting MCP-3 is key in promoting bone creation and stopping excessive bone loss. This was partly due to MCP-3's interaction with specific cell receptors and signaling pathways that affect bone cell activity. This research paves the way for future studies on MCP-3 as a target for bone-strengthening therapies, potentially leading to new treatments for diseases that weaken bones. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.
키워드
- 제목
- The MCP-3/Ccr3 axis contributes to increased bone mass by affecting osteoblast and osteoclast differentiation
- 저자
- Kim, Jung Ha; Kim, Kabsun; Kim, Inyoung; Seong, Semun; Che, Xiangguo; Choi, Je-Yong; Koh, Jeong-Tae; Kim, Nacksung
- 발행일
- 2024-11
- 유형
- Article
- 권
- 56
- 호
- 11
- 페이지
- 2465 ~ 2474
- 언어
- ENG
- 출판사
- SPRINGERNATURE
- 발행국가
- 영국
- 분량
- 10 페이지
- ISSN
- E 2092-6413
P 1226-3613